These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. Płoski R; Brand OJ; Jurecka-Lubieniecka B; Franaszczyk M; Kula D; Krajewski P; Karamat MA; Simmonds MJ; Franklyn JA; Gough SC; Jarząb B; Bednarczuk T PLoS One; 2010 Nov; 5(11):e15512. PubMed ID: 21124799 [TBL] [Abstract][Full Text] [Related]
3. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis. Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319 [TBL] [Abstract][Full Text] [Related]
4. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Liu L; Wu HQ; Wang Q; Zhu YF; Zhang W; Guan LJ; Zhang JA Endocr J; 2012; 59(8):717-23. PubMed ID: 22673349 [TBL] [Abstract][Full Text] [Related]
5. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. Hiratani H; Bowden DW; Ikegami S; Shirasawa S; Shimizu A; Iwatani Y; Akamizu T J Clin Endocrinol Metab; 2005 May; 90(5):2898-903. PubMed ID: 15741259 [TBL] [Abstract][Full Text] [Related]
6. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Yin X; Latif R; Bahn R; Tomer Y; Davies TF Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838 [TBL] [Abstract][Full Text] [Related]
7. Association of the TSHR gene with Graves' disease: the first disease specific locus. Dechairo BM; Zabaneh D; Collins J; Brand O; Dawson GJ; Green AP; Mackay I; Franklyn JA; Connell JM; Wass JA; Wiersinga WM; Hegedus L; Brix T; Robinson BG; Hunt PJ; Weetman AP; Carey AH; Gough SC Eur J Hum Genet; 2005 Nov; 13(11):1223-30. PubMed ID: 16106256 [TBL] [Abstract][Full Text] [Related]
8. Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population. Liu BL; Yang SY; Liu W; Xue LQ; Chen X; Pan CM; Gu ZH; Zhan M; Zhang XM; Liang J; Gao GQ; Du WH; Yuan GY; Ying R; Zhao SX; Song HD Eur J Endocrinol; 2014 Jan; 170(1):109-19. PubMed ID: 24144966 [TBL] [Abstract][Full Text] [Related]
9. Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis. Xiong H; Wu M; Yi H; Wang X; Wang Q; Nadirshina S; Zhou X; Liu X Sci Rep; 2016 Jul; 6():30356. PubMed ID: 27456991 [TBL] [Abstract][Full Text] [Related]
10. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy. Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543 [TBL] [Abstract][Full Text] [Related]
11. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease. Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730 [TBL] [Abstract][Full Text] [Related]
12. TSHR Gene (rs179247) Polymorphism and Susceptibility to Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. Zufry H; Hariyanto TI Endocrinol Metab (Seoul); 2024 Aug; 39(4):603-614. PubMed ID: 39086275 [TBL] [Abstract][Full Text] [Related]
13. Analysis of chosen polymorphisms rs2476601 a/G - PTPN22, rs1990760 C/T - IFIH1, rs179247 a/G - TSHR in pathogenesis of autoimmune thyroid diseases in children. Rydzewska M; Góralczyk A; Gościk J; Wawrusiewicz-Kurylonek N; Bossowska A; Krętowski A; Bossowski A Autoimmunity; 2018 Jun; 51(4):183-190. PubMed ID: 29973096 [TBL] [Abstract][Full Text] [Related]
14. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904 [TBL] [Abstract][Full Text] [Related]
16. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Ban Y; Greenberg DA; Concepcion ES; Tomer Y Thyroid; 2002 Dec; 12(12):1079-83. PubMed ID: 12593721 [TBL] [Abstract][Full Text] [Related]
17. Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Colobran R; Armengol Mdel P; Faner R; Gärtner M; Tykocinski LO; Lucas A; Ruiz M; Juan M; Kyewski B; Pujol-Borrell R Hum Mol Genet; 2011 Sep; 20(17):3415-23. PubMed ID: 21642385 [TBL] [Abstract][Full Text] [Related]
18. The genetics of the thyroid stimulating hormone receptor: history and relevance. Davies TF; Yin X; Latif R Thyroid; 2010 Jul; 20(7):727-36. PubMed ID: 20578897 [TBL] [Abstract][Full Text] [Related]
19. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease. Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229 [TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating hormone receptor and its role in Graves' disease. Chistiakov DA Mol Genet Metab; 2003 Dec; 80(4):377-88. PubMed ID: 14654350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]